PictureTel names Bond as new chief executiveVideoconferencing developer PictureTel has tapped Bruce Bond as president and CEO, effective March 1. Bond replaces Dr. Norman Gaut, who will continue to serve as chairman. Bond previously was CEO at
Videoconferencing developer PictureTel has tapped Bruce Bond as president and CEO, effective March 1. Bond replaces Dr. Norman Gaut, who will continue to serve as chairman. Bond previously was CEO at ANS, America Online's networking subsidiary that was recently sold to WorldCom.
In other PictureTel news, the Andover, MA-based firm has signed a joint development and marketing agreement with networking firm Fore Systems to develop standards-based LAN videoconferencing over ATM networks. Under the terms of the deal, Fore will develop ATM interfaces for PictureTel's family of LAN-based, H.323 videoconferencing client and server products. The addition of ATM network interfaces to the product family will enhance the quality, reliability, and performance of LAN-based videoconferencing over ATM networks, according to the firm.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.